SCHEMBL624394

SCHEMBL624394

CS(=O)(=O)N1CCC(Nc2nn3cc(-c4cnc(N5CCNCC5)c(C(F)(F)F)c4)nc3s2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 16/20 0.41
▸ CDK2 P24941 16/20 0.41
▸ CCND1 P24385 11/20 0.39
▸ CDK6 Q00534 11/20 0.39
▸ CDK1 P06493 10/20 0.39
▸ CCNB1 P14635 10/20 0.39
▸ CDK4 P11802 8/20 0.39
▸ CCND3 P30281 8/20 0.39
▸ IKBKB O14920 1/20 0.38
▸ CCNT1 O60563 2/20 0.37
▸ CDK7 P50613 2/20 0.37
▸ CDK9 P50750 2/20 0.37
▸ CCNH P51946 2/20 0.37
▸ MNAT1 P51948 2/20 0.37
▸ IDO1 P14902 1/20 0.36
▸ IDH1 O75874 1/20 0.35
▸ IDH2 P48735 1/20 0.35
▸ TDO2 P48775 1/20 0.35
▸ CCNB2 O95067 1/20 0.34
▸ CCNE2 O96020 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626704 0.92 CCNE1 (0.43) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL625861 0.87 GPR119 (0.46) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL626207 0.86 MAP3K12 (0.46) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL624393 0.85 FYN (0.46) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL626165 0.80 IDO1 (0.47) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL625236 0.78 MAP3K12 (0.45) CDK5CDK5R1
SCHEMBL625754 0.77 MAP3K12 (0.40) —
SCHEMBL626703 0.77 PIK3CA (0.53) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL626172 0.76 DYRK1A (0.38) CCNE1CDK2CCND1CDK6CDK1
SCHEMBL626187 0.75 JAK3 (0.38) CCNE1CDK2CCND1CDK6CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 — — WO disclosed
Send feedback